Eterna Therapeutics Inc.

NASDAQ (USD): Eterna Therapeutics Inc. (ERNA)

Last Price

0.458

Today's Change

+0.149 (48.22%)

Day's Change

0.432 - 0.96

Trading Volume

567,523,762

Overview

Market Cap

23 Million

Shares Outstanding

51 Million

Avg Volume

898,911

Avg Price (50 Days)

0.54

Avg Price (200 Days)

1.44

PE Ratio

-0.06

EPS

-8.31

Earnings Announcement

12-Mar-2025

Previous Close

0.31

Open

0.51

Day's Range

0.4324 - 0.96

Year Range

0.22 - 2.63

Trading Volume

568,206,237

Price Change Highlight

1 Day Change

48.22%

5 Day Change

48.12%

1 Month Change

58.48%

3 Month Change

-57.98%

6 Month Change

-77.66%

Ytd Change

24.12%

1 Year Change

-70.64%

3 Year Change

-99.29%

5 Year Change

-99.50%

10 Year Change

-99.95%

Max Change

-99.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment